Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation from EMA's CHMP committee is based on a robust analytical, non-clinical and clinical data package comparing the biosimilar...
Hence then, the article about golimumab biosimilar gotenfia from stada and bio thera receives positive chmp opinion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion )
Also on site :
- ‘World of Warcraft’ Just Upgraded Its Best City for the First Time in 20 Years, and Now It’s Perfect
- Denver’s historic Brown Palace Hotel listed for sale
- White House Mocks Kesha Over Singer’s Outrage About “Disgusting” Use Of Song In Military Posting; She Responds: “Stop Using My Music, Perverts”